Try our Advanced Search for more refined results

Cherokee Nation, The v. Johnson & Johnson, Inc. et al

Track this case

Case Number:

6:15-cv-00280

Court:

Oklahoma Eastern

Nature of Suit:

Other Statutory Actions

Judge:

James H. Payne

Firms

Companies

Sectors & Industries:

  1. April 07, 2016

    J&J Must Face Cherokee Risperdal Suit In State Court

    Johnson & Johnson and a subsidiary must face in an Oklahoma state court the Cherokee Nation's lawsuit over the undisclosed side effects of antipsychotic drug Risperdal, a federal judge ruled Wednesday, finding that the federal court lacked jurisdiction.

  2. March 04, 2016

    J&J Fights To Keep Cherokee Risperdal Suit In Federal Court

    Johnson & Johnson and a subsidiary doubled down on its fight to keep the Cherokee Nation's suit over undisclosed side effects of antipsychotic Risperdal out of state court on Friday, telling an Oklahoma federal judge that the tribe's arguments amount to conclusory allegations without factual support.

  3. February 16, 2016

    Cherokee Nation Wants Risperdal Suit Back In State Court

    The Cherokee Nation told an Oklahoma federal judge Monday its lawsuit against Johnson & Johnson and subsidiary Janssen Pharmaceuticals Inc. belongs in state court, asserting the drug manufacturers had not proven that federal jurisdiction applies in the suit over undisclosed side effects of Janssen's antipsychotic drug Risperdal.

  4. February 02, 2016

    J&J Fights Cherokee Bid To Move Risperdal Lawsuit

    Johnson & Johnson and subsidiary Janssen Pharmaceuticals told an Oklahoma federal judge Monday that a holding company for tribal businesses and not the tribe itself is the rightful plaintiff in the Cherokee Nation's suit over the undisclosed side effects of Janssen's anti-psychotic drug Risperdal.

  5. December 14, 2015

    Judge Unsure Whether To Remand Cherokees' Risperdal Suit

    An Oklahoma federal judge on Monday put off ruling on whether to keep in federal court the Cherokee Nation's mislabeling suit over a Johnson & Johnson subsidiary's antipsychotic drug Risperdal, ordering discovery for jurisdictional issues.

  6. September 01, 2015

    J&J Says Cherokees' Risperdal Suit Should Stay Federal

    Johnson & Johnson Inc. and subsidiary Janssen Pharmaceuticals Inc. are fighting to keep a dispute over the mislabeling of antipsychotic drug Risperdal in federal court, arguing in a motion Monday that the Cherokee Nation's suit heavily depends on proving a federal law violation.

  7. August 17, 2015

    Cherokees Want J&J Risperdal Suit Back In Okla. State Court

    The Cherokee Nation urged an Oklahoma federal judge Monday to send back to state court a suit alleging Johnson & Johnson Inc. and subsidiary Janssen Pharmaceuticals Inc. misbranded the antipsychotic drug Risperdal, arguing the federal court lacks jurisdiction over the tribe's claims.

  8. July 29, 2015

    J&J, Janssen Face Risperdal Suit From Cherokee Nation

    Johnson & Johnson Inc. and subsidiary Janssen Pharmaceuticals Inc. removed a suit to Oklahoma federal court in which the Cherokee Nation claims that the companies misbranded its anti-psychotic Risperdal and failed to disclose the drug's risk to the elderly.